Pfizer-BioNTech COVID Vaccine Receives Full FDA Approval

August 23, 2021

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. “The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.”
Moderna filed its requests for full approval after Pfizer, and Johnson & Johnson is expected to go through the same steps in the coming months.





Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.